Details for New Drug Application (NDA): 009789
✉ Email this page to a colleague
The generic ingredient in MYLAXEN is hexafluorenium bromide. There is one drug master file entry for this compound. Additional details are available on the hexafluorenium bromide profile page.
Summary for 009789
Tradename: | MYLAXEN |
Applicant: | Medpointe Pharm Hlc |
Ingredient: | hexafluorenium bromide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription